On May 4, 2022, Eli Lilly and Company announced that at its annual general meeting of shareholder held on May 2, 2022, a shareholder proposal requesting to disclose lobbying activities and alignment with public policy positions and statements was not approved.
Market Closed -
Other stock markets
|
After market 07:41:09 pm | |||
724.9 USD | -1.00% | 727.3 | +0.33% |
Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.35% | 653B | |
+24.52% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.34% | 233B | |
+5.40% | 201B | |
-10.27% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Declaration of Voting Results by Eli Lilly and Company